Smith & Nephew plc (NYSE:SNN) is one of the best medical device stocks to invest in right now. Canaccord cut the price target on Smith & Nephew plc (NYSE:SNN) to $32 from $35 on April 24 and ...

Track conference calls, annual meetings, summits, analyst days and other corporate events scheduled for Smith & Nephew PLC. Use the full market events calendar to scan activity across all tickers.

Smith & Nephew SNATS (NYSE:SNN) reported second-quarter underlying revenue growth of 1.6%, below management’s expectations, as continued strength in Sports Medicine and ENT was offset by weakness in U ...

Smith & Nephew plc (NYSE:SNN) is one of the best robotic surgery stocks to buy. Bernstein cut the price target on Smith & Nephew plc (NYSE:SNN) to $31.85 from $36.20 on May 11, maintaining a Market ...

Smith & Nephew (LON:SN)plc (NYSE:SNN) recently announced favorable one-year results of the STITCH Study evaluating its NOVOSTITCH Meniscal Repair System. This can be considered a major step toward the ...

Detailed price information for Smith & Nephew Snats ADR (SNN-N) from The Globe and Mail including charting and trades.

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced ...

1 Day S1NN34 -6.48% DJIA -0.25% S&P 500 -0.45% Nasdaq -1.16% Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...